Skip to content

Validation of Structured Light Plethysmography

Validation of Structured Light Plethysmography Against Spirometry in Children and Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02598336
Acronym
SLPvsPNT
Enrollment
41
Registered
2015-11-05
Start date
2011-01-31
Completion date
2017-09-30
Last updated
2018-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease

Keywords

Structured Light Plethysmography, Spirometry, Pneumotachograph

Brief summary

Measurements of Structured Light Plethysmography (SLP) using a chest wall movement based method will be compared to those obtained by spirometry using a flow based pneumotachograph method. This study will enable validation of SLP in children and adults by allowing direct comparison of simultaneous measurements of breathing sequences using the two measurement techniques. The investigators will also examine, in a group of normal adults, repeatability of the agreement between the two devices, and whether the agreement is affected by a change in tidal breathing parameters.

Detailed description

Measurements using the Structured Light Plethysmography method will be compared to those obtained by spirometry using a flow based pneumotachograph. Spirometry is the gold standard for measuring lung function in both clinical support and research roles. Modern spirometers are high precision, reliable instruments enabling a large numbers of parameters relating to lung volumes and the rate of emptying the lungs during a forced expiration to be measured. The most common and accurate method to measure the patient's forced expiration is via pneumotachograph which measures the flow of air through a mouthpiece and integrates the signal to derive the volume expired. Structured Light Plethysmography (SLP) system that measures changes of the chest and abdominal wall movement during breathing by modelling the thorax and abdominal surface defined by a projected structured light pattern which enables a grid of virtual parts to be formed, the movement of which is recorded by digital cameras. SLP provides non-contact assessment to provide lung function data utilising structured light technologies and enhanced imaging processing. In this study direct comparison will be made of measurements recorded simultaneously using the two measuring devices in children and adults. To examine repeatability of the agreement between tidal breathing parameters measured by two techniques, repeated measurements will be performed in each of a group of normal adult subjects. The investigators will also examine whether the agreement is affected by a change in tidal breathing parameters. To obtain a change in tidal breathing parameters, measurements will be recorded during resting spontaneous breathing and after a period of exercise to elevate Respiratory Rate.

Interventions

Non contact device that uses light to record displacement of the anterior thorax and abdomen region

DEVICEPneumotachograph Spirometry

Device that measures airflow at the mouth using a mouthpiece

Sponsors

Cambridge University Hospitals NHS Foundation Trust
CollaboratorOTHER
University of Cambridge
CollaboratorOTHER
Pneumacare Ltd
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* For the patient group, any patient attending the outpatient department or the Lung Function Laboratory * For the Healthy Normals group, any adult between 18 and 80 years with no current or previous respiratory condition.

Exclusion criteria

* A current cold or other viral infection * chest surgery within 4 weeks * Haemoptysis of unknown origin the (forced expiratory manoeuvre may aggravate the underlying condition) * Pneumothorax * Unstable respiratory or cardiovascular status (forced expiratory manoeuvre may worsen angina or cause changes in blood pressure) or recent myocardial infarction or pulmonary embolus * Recent eye surgery * Presence of an acute disease process that might interfere with test performance (e.g. Nausea, vomiting)

Design outcomes

Primary

MeasureTime frameDescription
Forced Expiratory Volume in one second (FEV1) measured in litres per second5 minutesThe volume of air a person can exhale in one second during a maximal forced breath
Peak Expiratory Flow (PEF) measured in litres per second5 minutesThe maximal flow a person can achieve during a maximal forced breath
Forced Vital Capacity (FVC) measured in Litres5 minutesThe volume of air a person can exhale during a maximal forced breath

Secondary

MeasureTime frameDescription
Inspiratory Time (tI) measured in seconds5 minutesTimings derived from the Respiratory Waveforms
Expiratory Time (tE) measured in seconds5 minutesTimings derived from the Respiratory Waveforms
Total breath time (tTot) measured in seconds5 minutesTimings derived from the Respiratory Waveforms
Inspiratory/expiratory ratio (tI/tE) expressed as a ratio5 minutesTiming ratios derived from the Respiratory Waveforms
The duty cycle (tI/tTot) expressed as a ratio5 minutesTiming ratios derived from the Respiratory Waveforms
Respiratory Waveform5 minutesVisual comparison of respiratory waveform shape and amplitude produced by pneumotachograph and SLP.
Respiratory Rate (RR) measured in seconds5 minutesTmings derived from the Respiratory Waveforms

Other

MeasureTime frameDescription
Inspiratory over Expiratory flow at 50 percent of tidal displacement (IE50) expressed at a ratio5 minutesFlow ratios derived from the Respiratory Waveforms

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026